Simulating the tumor microenvironment-advances in building a vascularized model of hepatocellular carcinoma through 3D bioprinting.
作者信息
Du Liwei, Yang Huayu
机构信息
Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC & Chinese Academy of Medical Sciences (CAMS), Beijing, China.
出版信息
Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):882-884. doi: 10.21037/hbsn-24-154. Epub 2024 Sep 26.
Abstract
摘要
相似文献
1
Simulating the tumor microenvironment-advances in building a vascularized model of hepatocellular carcinoma through 3D bioprinting.模拟肿瘤微环境——通过3D生物打印构建血管化肝细胞癌模型的进展
Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):882-884. doi: 10.21037/hbsn-24-154. Epub 2024 Sep 26.
2
Recent advances of three-dimensional bioprinting technology in hepato-pancreato-biliary cancer models.三维生物打印技术在肝胰胆管癌模型中的最新进展
Front Oncol. 2023 Apr 28;13:1143600. doi: 10.3389/fonc.2023.1143600. eCollection 2023.
3
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine.用于个性化医疗的原发性人类肝细胞癌的三维生物打印
Biomaterials. 2021 Jan;265:120416. doi: 10.1016/j.biomaterials.2020.120416. Epub 2020 Sep 22.
4
Advances in tissue engineering of vasculature through three-dimensional bioprinting.通过三维生物打印实现的血管组织工程进展。
Dev Dyn. 2021 Dec;250(12):1717-1738. doi: 10.1002/dvdy.385. Epub 2021 Jul 2.
5
Advances in tumor microenvironment: Applications and challenges of 3D bioprinting.肿瘤微环境的研究进展：3D 生物打印的应用和挑战。
Biochem Biophys Res Commun. 2024 Oct 20;730:150339. doi: 10.1016/j.bbrc.2024.150339. Epub 2024 Jul 8.
6
Recent advances in 3D bioprinting for cancer research: From precision models to personalized therapies.三维生物打印在癌症研究中的最新进展：从精准模型到个性化治疗。
Drug Discov Today. 2024 Apr;29(4):103924. doi: 10.1016/j.drudis.2024.103924. Epub 2024 Feb 22.
7
3D Bioprinting for Vascularized Tissue Fabrication.用于血管化组织构建的3D生物打印
Ann Biomed Eng. 2017 Jan;45(1):132-147. doi: 10.1007/s10439-016-1653-z. Epub 2016 May 26.
8
Mini-review: advances in 3D bioprinting of vascularized constructs.综述：血管化构建体的 3D 生物打印技术进展。
Biol Direct. 2020 Nov 2;15(1):22. doi: 10.1186/s13062-020-00273-4.
9
Directly coaxial 3D bioprinting of large-scale vascularized tissue constructs.直接同轴 3D 生物打印大规模血管化组织构建体。
Biofabrication. 2020 May 11;12(3):035014. doi: 10.1088/1758-5090/ab7e76.
10
3D Bioprinting for Tumor Metastasis Research.三维生物打印在肿瘤转移研究中的应用。
ACS Biomater Sci Eng. 2023 Jun 12;9(6):3116-3133. doi: 10.1021/acsbiomaterials.3c00239. Epub 2023 Apr 25.
引用本文的文献
1
Three-dimensional (3D) bioprinted co-culture models: a new paradigm for reproducing the tumor microenvironment and precision therapy.三维（3D）生物打印共培养模型：再现肿瘤微环境和精准治疗的新范式。
Hepatobiliary Surg Nutr. 2025 Jun 1;14(3):482-485. doi: 10.21037/hbsn-2025-297. Epub 2025 May 26.
本文引用的文献
1
Precision treatment in advanced hepatocellular carcinoma.晚期肝细胞癌的精准治疗。
Cancer Cell. 2024 Feb 12;42(2):180-197. doi: 10.1016/j.ccell.2024.01.007.
2
Prediction of Clinical Precision Chemotherapy by Patient-Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases.通过基于患者的结直肠癌及其肝转移的 3D 生物打印模型预测临床精准化疗。
Adv Sci (Weinh). 2024 Jan;11(2):e2304460. doi: 10.1002/advs.202304460. Epub 2023 Nov 16.
3
Progress in patient-derived liver cancer cell models: a step forward for precision medicine.患者源性肝癌细胞模型的研究进展：迈向精准医学的一步。
Acta Biochim Biophys Sin (Shanghai). 2023 Nov 25;55(11):1707-1717. doi: 10.3724/abbs.2023224.
4
Guidelines for hepatobiliary cancers: treatment strategies in the East and West.肝胆癌诊疗指南：东西方的治疗策略
Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):580-584. doi: 10.21037/hbsn-23-225. Epub 2023 Jul 17.
5
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma.肝细胞癌根治性治疗后辅助使用阿替利珠单抗-贝伐珠单抗。
Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):435-439. doi: 10.21037/hbsn-23-203. Epub 2023 May 22.
6
Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma.乐伐替尼在肝细胞癌患者治疗策略中的适用性。
Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):248-251. doi: 10.21037/hbsn-23-91. Epub 2023 Mar 27.
7
A new era for hepatocellular carcinoma.肝细胞癌的新时代。
Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):135-136. doi: 10.21037/hbsn-23-10. Epub 2023 Jan 16.
8
Core-shell bioprinting of vascularizedliver sinusoid models.核心壳层生物打印构建血管化肝脏窦模型。
Biofabrication. 2022 Sep 27;14(4). doi: 10.1088/1758-5090/ac9019.
9
3D Liver Tissue Model with Branched Vascular Networks by Multimaterial Bioprinting.多材料生物打印构建具有分支血管网络的 3D 肝脏组织模型。
Adv Healthc Mater. 2021 Dec;10(23):e2101405. doi: 10.1002/adhm.202101405. Epub 2021 Oct 20.
10
Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.乐伐替尼对比索拉非尼用于不可切除肝细胞癌的一线治疗：来自一项随机、开放标签、非劣效、III 期临床试验的患者报告结局。
Lancet Gastroenterol Hepatol. 2021 Aug;6(8):649-658. doi: 10.1016/S2468-1253(21)00110-2. Epub 2021 Jun 2.
Zotero 插件